Oracle (NYSE: ORCL) is priced at just 14 times forward earnings, a steep discount to its 21x five-year average, even as the company targets free cash flow that Wall Street has barely begun to price in.
That target, more than $30 billion in free cash flow by fiscal 2029, is more than double what the analyst consensus currently projects, suggesting investors may be underestimating the scale of Oracle’s AI infrastructure buildout returns.
The stock shed 14% across the past week, battered by two separate forces that compounded each other in quick succession.
The first was a $20 billion capital raise Oracle had already committed to, capping its new funding requirements through fiscal 2030 at that amount when it announced the ceiling on Oct. 28.
Before markets opened on the day of pricing, Oracle filed the full offering, selling 86.2 million shares at $116 per share alongside $10 billion of notes carrying interest rates between 7% and 8.65%.
Despite the raise being a known event, the stock dropped 9% on that single day, reflecting market sensitivity to dilution even when the terms were largely anticipated.
The actual financial burden is more contained than the share price reaction implied, adding roughly 3% to the share count and approximately $780 million per year in interest costs.
Against fiscal 2028 earnings estimates of $11.08 per share, the dilution and interest expense combined amount to no more than 55 cents per share, a manageable drag on a business generating that level of profitability.
The second blow came from the broader AI trade unwinding after Amazon reported results showing its trailing free cash flow swung to a $42.4 billion outflow driven by AI infrastructure spending, rattling the entire sector.
The Nasdaq 100 fell more than 3% on Oct. 30, a session that carried no Oracle-specific news, pulling the stock down alongside peers on sentiment alone.
CoreWeave (NASDAQ: CRWV), which carries comparable AI exposure but costlier debt, fared worse, declining 24% over the same period, with its most recent unsecured bonds priced at 9.75% and 9.625%, well above Oracle’s new 7% to 8.65% range.
That spread illustrates a meaningful difference in borrowing costs and perceived credit risk between the two companies as both compete for AI infrastructure capital.
With its funding now secured through fiscal 2030 and no further capital raises expected under the cap Oracle itself set, the path forward depends on internal cash generation rather than external markets.
December’s second-quarter earnings report will serve as the first concrete checkpoint on whether Oracle’s cash flow trajectory is tracking toward those ambitious fiscal 2029 goals.
The 41 analysts currently covering Oracle carry an average price target of $235, implying significant upside from current levels if the company’s AI infrastructure investments begin to generate the returns the company projects.
At 14 times forward earnings, the market is effectively pricing Oracle as though its buildout will not pay off, a skepticism that becomes harder to sustain if cash flow growth continues to outpace consensus in coming quarters.
